These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 28472613)

  • 21. Expression of programmed cell death ligand 1 (PD-L1) in advanced stage EBV-associated extranodal NK/T cell lymphoma is associated with better prognosis.
    Kim WY; Jung HY; Nam SJ; Kim TM; Heo DS; Kim CW; Jeon YK
    Virchows Arch; 2016 Nov; 469(5):581-590. PubMed ID: 27595782
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transcriptional profiling of Epstein-Barr virus (EBV) genes and host cellular genes in nasal NK/T-cell lymphoma and chronic active EBV infection.
    Zhang Y; Ohyashiki JH; Takaku T; Shimizu N; Ohyashiki K
    Br J Cancer; 2006 Feb; 94(4):599-608. PubMed ID: 16449999
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A case of clinically aggressive EBV-negative ENKTL in a non-Asian female patient.
    Kent T; Scott G; Seifert R
    J Hematop; 2023 Mar; 16(1):33-38. PubMed ID: 38175370
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extranodal natural-killer/T-cell lymphoma, nasal type: An immunomorphological study from a regional cancer institute in India.
    Agrawal M; Champaka G; Amirtham U; Jacob LA; Premalata CS
    J Cancer Res Ther; 2022; 18(4):1137-1143. PubMed ID: 36149173
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methotrexate-associated lymphoproliferative disorder presenting as extranodal NK/T-cell lymphoma arising in the lungs.
    Tajima S; Takanashi Y; Koda K; Fukayama M
    Pathol Int; 2015 Dec; 65(12):661-5. PubMed ID: 26459854
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytotoxic peripheral T-cell lymphomas and EBV-positive T/NK-cell lymphoproliferative diseases: emerging concepts, recent advances, and the putative role of clonal hematopoiesis. A report of the 2022 EA4HP/SH lymphoma workshop.
    Climent F; Nicolae A; de Leval L; Dirnhofer S; Leoncini L; Ondrejka SL; Soma L; Wotherspoon A; Zamo A; Quintanilla-Martinez L; Ng SB
    Virchows Arch; 2023 Sep; 483(3):333-348. PubMed ID: 37646869
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disorder in children and young adults has similar molecular signature to extranodal nasal natural killer/T-cell lymphoma but shows distinctive stem cell-like phenotype.
    Ng SB; Ohshima K; Selvarajan V; Huang G; Choo SN; Miyoshi H; Shimizu N; Reghunathan R; Chua HC; Yeoh AE; Quah TC; Koh LP; Tan PL; Chng WJ
    Leuk Lymphoma; 2015; 56(8):2408-15. PubMed ID: 25382618
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of Extranodal NK/T-cell Lymphoma Nasal Type in Cerebrum Following Epstein-Barr Virus-positive Uveitis.
    Imai A; Takase H; Imadome KI; Matsuda G; Ohnishi I; Yamamoto K; Kudo T; Tanaka Y; Maehara T; Miura O; Arai A
    Intern Med; 2017; 56(11):1409-1414. PubMed ID: 28566607
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clonal deleted latent membrane protein 1 variants of Epstein-Barr virus are predominant in European extranodal NK/T lymphomas and disappear during successful treatment.
    Halabi MA; Jaccard A; Moulinas R; Bahri R; Al Mouhammad H; Mammari N; Feuillard J; Ranger-Rogez S
    Int J Cancer; 2016 Aug; 139(4):793-802. PubMed ID: 27061907
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential clinical significance of pre-, interim-, and post-treatment plasma Epstein-Barr virus DNA load in NK/T-cell lymphoma treated with P-GEMOX protocol.
    Wang XX; Li PF; Bai B; Gao Y; Rong QX; Cai QQ; Lin SX; Zhang YJ; Li ZM; Jiang WQ; Huang HQ
    Leuk Lymphoma; 2019 Aug; 60(8):1917-1925. PubMed ID: 30646796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA profiling of Epstein-Barr virus-associated NK/T-cell lymphomas by deep sequencing.
    Motsch N; Alles J; Imig J; Zhu J; Barth S; Reineke T; Tinguely M; Cogliatti S; Dueck A; Meister G; Renner C; Grässer FA
    PLoS One; 2012; 7(8):e42193. PubMed ID: 22870299
    [TBL] [Abstract][Full Text] [Related]  

  • 32. T-cell receptor (TCR) phenotype of nodal Epstein-Barr virus (EBV)-positive cytotoxic T-cell lymphoma (CTL): a clinicopathologic study of 39 cases.
    Kato S; Asano N; Miyata-Takata T; Takata K; Elsayed AA; Satou A; Takahashi E; Kinoshita T; Nakamura S
    Am J Surg Pathol; 2015 Apr; 39(4):462-71. PubMed ID: 25634749
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T/NK cell type chronic active Epstein-Barr virus disease in adults: an underlying condition for Epstein-Barr virus-associated T/NK-cell lymphoma.
    Isobe Y; Aritaka N; Setoguchi Y; Ito Y; Kimura H; Hamano Y; Sugimoto K; Komatsu N
    J Clin Pathol; 2012 Mar; 65(3):278-82. PubMed ID: 22247563
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epstein-Barr virus-associated primary nodal T/NK-cell lymphoma shows a distinct molecular signature and copy number changes.
    Ng SB; Chung TH; Kato S; Nakamura S; Takahashi E; Ko YH; Khoury JD; Yin CC; Soong R; Jeyasekharan AD; Hoppe MM; Selvarajan V; Tan SY; Lim ST; Ong CK; Nairismägi ML; Maheshwari P; Choo SN; Fan S; Lee CK; Chuang SS; Chng WJ
    Haematologica; 2018 Feb; 103(2):278-287. PubMed ID: 29097495
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epstein-Barr virus reactivation in extranodal natural killer/T-cell lymphoma patients: a previously unrecognized serious adverse event in a pilot study with romidepsin.
    Kim SJ; Kim JH; Ki CS; Ko YH; Kim JS; Kim WS
    Ann Oncol; 2016 Mar; 27(3):508-13. PubMed ID: 26658891
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The clinical significance of Epstein-Barr virus DNA in peripheral blood mononuclear cells in patients with non-Hodgkin lymphoma.
    Chen Y; Zheng X; Chen B; Yang X; Zheng J; Zheng Z; Yang T; Liu T; Hu J
    Leuk Lymphoma; 2017 Oct; 58(10):2349-2355. PubMed ID: 28306367
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Wait and see: a case of EBV + cutaneous extranodal NK/T-type lymphoma with indolent behaviour.
    Aromolo IF; Pescia C; Simeoli D; Violetti SA; Ferla V; Rossi FG; Croci GA
    Virchows Arch; 2024 Jun; 484(6):1029-1032. PubMed ID: 37870613
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extranodal NK/T-cell lymphoma: toward the identification of clinical molecular targets.
    Schmitt C; Sako N; Bagot M; Huang Y; Gaulard P; Bensussan A
    J Biomed Biotechnol; 2011; 2011():790871. PubMed ID: 21541194
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular pathogenic pathways in extranodal NK/T cell lymphoma.
    de Mel S; Hue SS; Jeyasekharan AD; Chng WJ; Ng SB
    J Hematol Oncol; 2019 Apr; 12(1):33. PubMed ID: 30935402
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LMP1 and LMP2A are potential prognostic markers of extranodal NK/T-cell lymphoma, nasal type (ENKTL).
    Mao Y; Zhang DW; Zhu H; Lin H; Xiong L; Cao Q; Liu Y; Li QD; Xu JR; Xu LF; Chen RJ
    Diagn Pathol; 2012 Dec; 7():178. PubMed ID: 23237707
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.